MarketCap
Facebook
X
Telegram
MiMedx Group Net Income | MDXG
Net profit is a financial indicator that reflects the remaining amount of money after deducting all expenses and taxes from the company’s total income over a certain period of time. It is one of the key indicators of a company’s financial stability and success.
Net profit is the portion of total profit remaining after taxes and depreciation have been deducted.[1]
It is the result of a company’s operations and reflects its efficiency in managing resources, controlling expenses, and generating income. It includes all operating revenues and expenses, such as sales of goods or services, production costs, administrative expenses, taxes, and other financial metrics.
The calculation of net profit includes the deduction of all necessary expenses such as employee salaries, rent, utilities, taxes, and other mandatory payments. After all these expenses are deducted from the total income, the remaining amount is considered the company’s net profit.
Net profit is an important indicator of a company’s financial health, as it reflects its ability to generate earnings and manage its finances. High net profit indicates business success, competitiveness, and efficiency in resource utilization. It also allows a company to invest in its development, pay dividends to shareholders, or create reserve funds for unforeseen situations.
It serves as a basis for calculating other financial indicators, such as return on sales, return on assets, or return on equity. It is also used to assess the performance of management and make decisions regarding the future development of the company.
However, it should be noted that net profit can be affected by various factors, such as economic conditions, changes in legislation, market competition, and other external influences. Therefore, companies must be prepared for possible changes and take measures to ensure the stability of their financial results.
Annual Net Income MiMedx Group
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 48.6 M | 42.4 M | 58.2 M | -30.2 M | -10.3 M | -49.3 M | -25.6 M | -30 M | 64.7 M | 390 K | 29.4 M | 6.22 M | -4.11 M | -7.66 M | -10.2 M | -11.4 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 64.7 M | -49.3 M | 4.46 M |
Quarterly Net Income MiMedx Group
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -14.8 M | -10.9 M | - | 16.7 M | 9.62 M | 7.02 M | - | 8.1 M | 17.6 M | 9.26 M | - | 8.53 M | 1.2 M | -4.98 M | - | -8.43 M | -10.9 M | -10.5 M | - | -2.34 M | -1.78 M | -8.38 M | -16.6 M | -19.4 M | -8.47 M | -4.82 M | -7.48 M | 12.4 M | -17.2 M | -13.3 M | -36.2 M | -178 K | 1.8 M | 4.62 M | 4.28 M | 44.1 M | 10.4 M | 6 M | 5.48 M | 3.32 M | 1.98 M | 1.2 M | 13.4 M | 6.55 M | 5.43 M | 4.09 M | 3.83 M | 3.7 M | -390 K | -922 K | -1.43 M | -307 K | -757 K | -1.62 M | -1.6 M | -4.22 M | -744 K | -1.09 M | -2.58 M | -1.77 M | -2.5 M | -3.35 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 44.1 M | -36.2 M | -163 K |
References
- Bhamornsiri, S., & Wiggins, C. (2001). Comprehensive income disclosures. The CPA Journal, 71(10), 54.
Net Income of other stocks in the Medical devices industry
| Issuer | Net Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AxoGen
AXGN
|
-15.7 M | $ 43.32 | 0.04 % | $ 1.99 B |  USA |
 |
Bruker Corporation
BRKR
|
-8.3 M | $ 59.67 | 0.18 % | $ 9.06 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
-638 K | $ 8.73 | 1.16 % | $ 637 M |  Israel |
 |
ClearPoint Neuro
CLPT
|
-25.5 M | $ 14.97 | 13.03 % | $ 424 M | USA |
 |
Conformis
CFMS
|
-50.5 M | - | - | $ 16.4 M | USA |
 |
CONMED Corporation
CNMD
|
47.1 M | $ 45.8 | 3.31 % | $ 1.42 B | USA |
 |
Cytosorbents Corporation
CTSO
|
-8.2 M | $ 4.91 | 0.75 % | $ 306 M | USA |
 |
Delcath Systems
DCTH
|
2.7 M | $ 15.96 | 1.8 % | $ 572 M | USA |
 |
Eargo
EAR
|
-157 M | - | - | $ 10.2 M | USA |
 |
AdaptHealth Corp.
AHCO
|
-70.8 M | $ 5.7 | 0.43 % | $ 770 M | USA |
 |
Electromed
ELMD
|
11.3 M | $ 27.57 | 0.11 % | $ 228 M | USA |
 |
Establishment Labs Holdings
ESTA
|
-51.1 M | $ 67.76 | 3.69 % | $ 2.01 B |  Costa-rica |
 |
Edwards Lifesciences Corporation
EW
|
1.07 B | $ 86.82 | 0.51 % | $ 50.8 B | USA |
 |
Align Technology
ALGN
|
410 M | $ 148.17 | 4.36 % | $ 10.7 B | USA |
 |
Helius Medical Technologies
HSDT
|
-40.9 M | $ 2.88 | 2.45 % | $ 63.5 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
-517 M | $ 15.53 | 2.76 % | $ 1.19 B | USA |
 |
Inogen
INGN
|
22.7 M | $ 5.09 | 2.55 % | $ 135 M | USA |
 |
Inspire Medical Systems
INSP
|
145 M | $ 69.06 | 0.57 % | $ 2.03 B | USA |
 |
IRIDEX Corporation
IRIX
|
-4.44 M | $ 0.63 | 0.08 % | $ 10.7 M | USA |
 |
IRadimed Corporation
IRMD
|
22.5 M | $ 86.35 | 0.08 % | $ 1.1 B | USA |
 |
Integer Holdings Corporation
ITGR
|
103 M | $ 126.32 | 0.02 % | $ 4.39 B | USA |
|
LENSAR
LNSR
|
-34.3 M | $ 7.15 | 0.14 % | $ 85.5 M | USA |
 |
Medigus Ltd.
MDGS
|
4.05 M | - | 10.28 % | $ 55.5 M | Israel |
 |
Apyx Medical Corporation
APYX
|
-11.2 M | $ 2.95 | 1.37 % | $ 121 M | USA |
 |
Cutera
CUTR
|
-57.2 M | - | -10.19 % | $ 1.99 M | USA |
 |
Medtronic PLC
MDT
|
4.8 B | $ 89.3 | 0.08 % | $ 114 B | USA |
 |
Accuray Incorporated
ARAY
|
-49.2 M | $ 0.23 | 1.0 % | $ 28.2 M | USA |
 |
Myomo
MYO
|
-15.6 M | $ 1.64 | 0.3 % | $ 68.6 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
-75 M | $ 0.7 | 0.45 % | $ 45.4 M | Israel |
 |
Nemaura Medical
NMRD
|
-14.1 M | - | -17.8 % | $ 2.74 M |  Britain |
 |
InspireMD
NSPR
|
-48.8 M | $ 0.74 | 0.16 % | $ 47.6 M | Israel |
 |
Orthofix Medical
OFIX
|
-92.2 M | $ 9.18 | 2.23 % | $ 364 M |  Curacao |
 |
Outset Medical
OM
|
-81.7 M | $ 3.09 | 5.45 % | $ 47 K | USA |
 |
Boston Scientific Corporation
BSX
|
2.89 B | $ 44.62 | 0.31 % | $ 66.1 B | USA |
 |
Insulet Corporation
PODD
|
247 M | $ 136.49 | 0.01 % | $ 9.6 B | USA |
 |
Profound Medical Corp.
PROF
|
-42.6 M | $ 5.74 | 0.16 % | $ 174 M |  Canada |
 |
Quanterix Corporation
QTRX
|
-107 M | $ 3.16 | 4.93 % | $ 135 M | USA |
 |
AVITA Medical
RCEL
|
-48.6 M | $ 10.95 | 0.61 % | $ 305 M |  Australia |
 |
Neovasc
NVCN
|
-24.9 M | - | - | $ 111 M | Canada |
 |
Sintx Technologies
SINT
|
-10.4 M | $ 1.78 | 3.98 % | $ 4.94 M | USA |
 |
Smith & Nephew plc
SNN
|
625 M | $ 26.82 | 0.07 % | $ 23.3 B | Britain |
 |
Inari Medical
NARI
|
-1.64 M | - | - | $ 4.23 B | USA |
 |
Sensus Healthcare
SRTS
|
-7.72 M | $ 3.03 | 0.32 % | $ 49.5 M | USA |
 |
Stryker Corporation
SYK
|
849 M | $ 273.4 | 0.38 % | $ 104 B | USA |
 |
Tactile Systems Technology
TCMD
|
19.1 M | $ 22.43 | 0.55 % | $ 513 M | USA |
 |
TELA Bio
TELA
|
-38.8 M | $ 1.3 | 0.71 % | $ 61 M | USA |
 |
Viemed Healthcare
VMD
|
15.4 M | $ 8.8 | 1.24 % | $ 342 M | USA |
 |
Varex Imaging Corporation
VREX
|
-70.3 M | $ 18.45 | 0.05 % | $ 764 M | USA |
 |
Sientra
SIEN
|
-22 M | - | -16.59 % | $ 10.3 M | USA |